title: Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
authors.affiliation: Merck SA, Alges, Portugal.
authors.forename: N
authors.initials: N
authors.lastname: Silverio
authors.affiliation: Merck SA, Alges, Portugal.
authors.forename: L
authors.initials: L
authors.lastname: Sequeira
authors.affiliation: EMD Serono, rockland, ME, USA.
authors.forename: D
authors.initials: D
authors.lastname: Meletiche